Position in NVS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$522,661
+$17,670 QoQ
Shares Held
3,335
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#865
of 1,603 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Range Financial Group LLC holds $24,424,846 across 12 Drug Manufacturers - General names. NVS ranks #9 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,427 | $6,509,307 | |
| 2 | JNJ |
Johnson & Johnson
|
20,421 | $5,186,321 | |
| 3 | AMGN |
Amgen Inc
|
13,553 | $4,907,812 | |
| 4 | NVO |
Novo Nordisk A S
|
54,505 | $2,612,969 | |
| 5 | ABBV |
AbbVie Inc.
|
5,435 | $1,367,663 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,837 | $912,527 | |
| 7 | GSK |
GSK plc
|
16,868 | $884,220 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,073 | $523,380 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $522,661 | 3,335 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $504,991 | 3,306 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $456,763 | 3,313 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $400,365 | 3,122 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $374,767 | 3,097 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $336,558 | 3,019 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $303,315 | 3,117 | Shares | Sole | 2025-01-07 | |
| 2024-06-30 | $459,481 | 4,316 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $534,239 | 5,523 | Shares | Sole | 2024-04-12 | |
| No filing history on record for this holder in this stock. | ||||||